Teva Pharmaceutical Indus...

NYSE: TEVA · Real-Time Price · USD
17.79
0.25 (1.43%)
At close: Aug 15, 2025, 12:39 PM

Teva Pharmaceutical Industries Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-492M -1.34B -1.7B -988M -463M -516M -615M -2.3B -2.33B -1.69B -2.41B -1.3B -1.06B -580M 456M 770M -3.87B -4.04B
Depreciation & Amortization
772M 1.03B 1.06B 1.06B 1.08B 1.12B 1.15B 1.19B 1.23B 1.29B 1.31B 1.32B 1.33B 1.28B 1.33B 1.41B 1.46B 1.53B
Stock-Based Compensation
97M 129M 123M 117M 119M 117M 121M 129M 124M 133M 125M 122M 122M 112M 119M 124M 127M 130M
Other Working Capital
-628M -638M -435M -611M -1.53B -1.69B -1.51B -1.43B -999M -478M 99M -1.03B -1.06B -2.02B -3.83B -4.32B -4.75B -4.48B
Other Non-Cash Items
2.1B 4.05B 5.22B 4.56B 3.37B 2.14B 1.1B 2.48B 3.37B 2.53B 2.48B 1.2B 339M 695M 714M 843M 5.79B 5.95B
Deferred Income Tax
-21M -445M -634M -634M -780M -400M -317M -194M 49M -990M -1.06B -1.35B -1.38B -284M -120M -27M -189M -474M
Change in Working Capital
-628M -638M -435M 136M -419M -205M -72M -148M 184M 334M 1.26B 1.19B 891M -66M -1.7B -2.44B -2.87B -2.6B
Operating Cash Flow
1.39B 1.58B 1.86B 2.47B 1.78B 1.68B 1.37B 1.16B 1.7B 1.49B 1.59B 1.07B 1.06B 1.15B 798M 673M 451M 506M
Capital Expenditures
-404M -501M -498M -488M -489M -511M -526M -549M -522M -530M -548M -559M -583M -569M -562M -585M -582M -600M
Cash Acquisitions
21M 22M -74M -146M -136M -81M n/a 91M 83M 45M 36M -256M -243M -145M n/a 518M 512M 435M
Purchase of Investments
-27M -70M -71M -58M -95M -54M -46M -43M -3M -1M -1M -13M 382M 348M 350M 306M -91M -57M
Sales Maturities Of Investments
40M 40M 40M -321M -371M n/a n/a 363M 374M 6M 6M 685M 703M 809M 853M 239M 223M 117M
Other Investing Acitivies
1.04B 999M 665M 745M 739M 777M 1.11B 975M 868M 870M 877M 589M 328M 699M 846M 904M 1.2B 1.28B
Investing Cash Flow
671M 532M 116M 215M 131M 572M 968M 837M 800M 677M 657M 733M 874M 1.18B 1.52B 1.42B 1.29B 1.12B
Debt Repayment
-2.05B -3.01B -1.64B -1.46B -1.96B -1B -1.7B -1.91B -1.77B -2.07B -1.37B -1.16B -1.97B -1.68B -2.17B -1.79B -1.79B -1.79B
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-365M -375M -150M -237M -313M -358M -212M -139M -137M -124M -117M -115M -43M -2M -6M -6M 110M 108M
Financial Cash Flow
-2.42B -3.38B -1.73B -1.63B -2.21B -1.29B -1.91B -2.05B -1.91B -2.2B -1.49B -1.28B -2.01B -1.68B -2.17B -1.8B -1.68B -1.68B
Net Cash Flow
-561M -1.29B 74M 1.07B -411M 816M 393M -8M 579M -74M 636M 213M -345M 507M 21M 218M 34M -61M
Free Cash Flow
986M 1.08B 1.36B 1.98B 1.29B 1.17B 842M 608M 1.17B 964M 1.04B 514M 476M 585M 236M 88M -131M -94M